Rafael Holdings, Inc. financial data

Symbol
RFL on NYSE
Industry
Pharmaceutical Preparations
Location
520 Broad Street, Newark, NJ
State of incorporation
DE
Fiscal year end
July 31
Latest financial report
10-K/A - Q2 2024 - Dec 20, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.14K % -78%
Debt-to-equity 10.4 % +518%
Return On Equity -44.6 % -501%
Return On Assets -40.5 % -455%
Operating Margin -14.9K % -234%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 34.4M USD -51%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 24.1M shares +1.77%
Weighted Average Number of Shares Outstanding, Diluted 24.1M shares +1.77%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 697K USD +152%
Cost of Revenue 37K USD
Research and Development Expense 5.01M USD +6.08%
General and Administrative Expense 9.34M USD +18.7%
Operating Income (Loss) -104M USD -740%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -72.9M USD -930%
Income Tax Expense (Benefit) 12K USD +100%
Net Income (Loss) Attributable to Parent -39.8M USD -460%
Earnings Per Share, Basic -1.67 USD/shares -457%
Earnings Per Share, Diluted -1.67 USD/shares -457%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.16M USD -38.2%
Accounts Receivable, after Allowance for Credit Loss, Current 201K USD -18%
Other Assets, Current 150K USD +35.1%
Assets, Current 70.5M USD -9.02%
Property, Plant and Equipment, Net 2.08M USD +24.4%
Intangible Assets, Net (Excluding Goodwill) 1.82M USD
Goodwill 3.05M USD
Other Assets, Noncurrent 27K USD -35.7%
Assets 87.8M USD -8.03%
Accounts Payable, Current 2.7M USD
Accrued Liabilities, Current 1.38M USD +324%
Liabilities, Current 7.24M USD +675%
Deferred Income Tax Liabilities, Net 73K USD
Other Liabilities, Noncurrent 5K USD -90.9%
Liabilities 10.5M USD +956%
Retained Earnings (Accumulated Deficit) -211M USD -23.3%
Stockholders' Equity Attributable to Parent 73.5M USD -25.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 77.4M USD -18.1%
Liabilities and Equity 87.8M USD -8.03%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.04M USD -42.6%
Net Cash Provided by (Used in) Financing Activities -48K USD -106%
Net Cash Provided by (Used in) Investing Activities 8.58M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.48M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.16M USD -38.2%
Deferred Tax Assets, Valuation Allowance 71.3M USD +40.1%
Deferred Tax Assets, Gross 71.4M USD +40.3%
Payments to Acquire Property, Plant, and Equipment 6K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -39.5M USD -433%
Lessee, Operating Lease, Liability, to be Paid 589K USD +333%
Property, Plant and Equipment, Gross 3.14M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 188K USD +224%
Lessee, Operating Lease, Liability, to be Paid, Year One 181K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 78K USD
Deferred Tax Assets, Operating Loss Carryforwards 61.2M USD +243%
Unrecognized Tax Benefits 6.22M USD
Additional Paid in Capital 264M USD +3.38%
Operating Leases, Future Minimum Payments, Due in Two Years 666K USD
Amortization of Intangible Assets 38K USD
Depreciation, Depletion and Amortization 17K USD -22.7%
Deferred Tax Assets, Net of Valuation Allowance 2.36M USD -95.4%
Share-based Payment Arrangement, Expense 2.01M USD +21.1%
Operating Leases, Future Minimum Payments, Due in Three Years 19K USD -99.3%
Operating Leases, Future Minimum Payments Due 155K USD -10.9%
Interest Expense 162K USD